|
Volumn 3, Issue 4, 2007, Pages 179-
|
Sodium channels in neuropathic pain - Friend or foe?
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBAMAZEPINE;
CATION CHANNEL;
GENE PRODUCT;
LIDOCAINE;
PROTEIN SCN9A;
SODIUM CHANNEL;
SODIUM CHANNEL NAV1.7;
UNCLASSIFIED DRUG;
VOLTAGE GATED SODIUM CHANNEL;
CLINICAL FEATURE;
CONGENITAL ANALGESIA;
EDITORIAL;
ERYTHROMELALGIA;
FAMILIAL DISEASE;
GENE MUTATION;
GENETIC VARIABILITY;
HEREDITY;
HOMOZYGOSITY;
HUMAN;
LINKAGE ANALYSIS;
MISSENSE MUTATION;
NERVE INJURY;
NEUROPATHIC PAIN;
NOCICEPTION;
NONSENSE MUTATION;
PAIN;
PAROXYSMAL EXTREME PAIN DISORDER;
PATHOGENESIS;
PHENOTYPE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
SIGNAL TRANSDUCTION;
SODIUM URINE LEVEL;
SYMPATHETIC NERVE CELL;
VOLTAGE CLAMP;
HUMANS;
MUTATION;
NEURALGIA;
SODIUM CHANNELS;
|
EID: 34247255517
PISSN: 1745834X
EISSN: 17458358
Source Type: Journal
DOI: 10.1038/ncpneuro0464 Document Type: Editorial |
Times cited : (4)
|
References (0)
|